Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival
- 2 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Immunology, Immunotherapy
- Vol. 70 (10), 2819-2833
- https://doi.org/10.1007/s00262-021-02877-9
Abstract
Background Cellular immunity against tumor cells is highly dependent on antigen presentation by major histocompatibility complex class I (MHC-I) molecules. However, few published studies have investigated associations between functional variants of MHC-I-related genes and clinical outcomes of lung cancer patients. Methods We performed a two-phase Cox proportional hazards regression analysis by using two previously published genome-wide association studies to evaluate associations between genetic variants in the MHC-I-related gene set and the survival of non-small cell lung cancer (NSCLC) patients, followed by expression quantitative trait loci analysis. Results Of the 7811 single-nucleotide polymorphisms (SNPs) in 89 genes of 1185 NSCLC patients in the discovery dataset of the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, 24 SNPs remained statistically significant after validation in additional 984 NSCLC patients from the Harvard Lung Cancer Susceptibility Study. In a multivariate stepwise Cox model, three independent functional SNPs (ERAP1 rs469783 T > C, PSMF1 rs13040574 C > A and NCF2 rs36071574 G > A) remained significant with an adjusted hazards ratio (HR) of 0.83 [95% confidence interval (CI) = 0.77-0.89, P = 8.0 x 10(-7)], 0.86 (0.80-0.93, P = 9.4 x 10(-5)) and 1.31 (1.11-1.54, P = 0.001) for overall survival (OS), respectively. Further combined genotypes revealed a poor survival in a dose-response manner in association with the number of unfavorable genotypes (P-trend < 0.0001 and 0.0002 for OS and disease-specific survival, respectively). Also, ERAP1 rs469783C and PSMF1 rs13040574A alleles were associated with higher mRNA expression levels of their genes. Conclusion These potentially functional SNPs of the MHC-I-related genes may be biomarkers for NSCLC survival, possibly through modulating the expression of corresponding genes.Funding Information
- National Institutes of Health (CA092824, 5U01CA209414, CA074386, CA090578, R01NS091307 and R56AG062302)
- The V Foundation for Cancer Research (D2017-19)
- the Duke Cancer Institute as part of the P30 Cancer Center Support Grant (NIH/NCI CA014236)
This publication has 53 references indexed in Scilit:
- Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based ChemotherapyJNCI Journal of the National Cancer Institute, 2011
- Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening TrialJNCI Journal of the National Cancer Institute, 2010
- SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studiesNucleic Acids Research, 2009
- Second hand smoke, age of exposure and lung cancer riskLung Cancer, 2008
- Immune surveillance: a balance between protumor and antitumor immunityCurrent Opinion in Genetics & Development, 2008
- The NCBI dbGaP database of genotypes and phenotypesNature Genetics, 2007
- A Bayesian Measure of the Probability of False Discovery in Genetic Epidemiology StudiesAmerican Journal of Human Genetics, 2007
- Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaCancer Immunology, Immunotherapy, 2007
- Estimation of time‐dependent area under the ROC curve for long‐term risk predictionStatistics in Medicine, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004